Immunomodulators and Biologics in Dermatologic Treatment

Dr. Neal Bhatia is a leading dermatologist in Southern California with extensive experience in treating a wide range of common and rare dermatological diseases.  After earning dual bachelor of science degrees in bacteriology and genetics from the University of Wisconsin, Dr. Bhatia completed his medical degree at the University of Wisconsin School of Medicine before completing residencies in internal medicine and dermatology at Medical College of Wisconsin in Milwaukee.  He serves as Director of Clinical Dermatology at Therapeutics Clinical Research and is Chief Medical Editor for the journal Practical Dermatology.  He has a background in immunology and has interests in mechanisms of therapy, skin cancer, and medical dermatology.  He has been involved in countless clinical trials as well.  Dr. Bhatia has served on the AAD Board of Directors as well as Vice President of the AAD in 2021, and he maintains memberships in several other professional organizations.

Introduction.- Mechanisms of Action: Targets for Immunomodulators.- Steroid and Non-Steroid Immunomodulators.- Biologics as Immunomodulators.- Combinations of topical and systemic Immunomodulators,- Nanotechnology and Immunomodulators.- Antibiotics and Antimicrobials as Immunomodulators.- Integrative Therapies as Immunomodulators.- Immunomodulators and Biologics for Follicular and Neutrophilic Cutaneous Disorders.- Immunomodulators for Common Dermatologic Disorders.- Prescribing and Advocating for Immunomodulators in Dermatology Practice.- Conclusion.